Cowen analyst Yaron Werber raised the firm’s price target on Argenx to $458 from $441 and keeps an Outperform rating on the shares. The analyst updated the firm’s model to align with current Vyvgart sales trends, European launch expectations, and expansion into additional indications.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ARGX:
- argenx Announces Extraordinary General Meeting of Shareholders on February 27, 2023 to Appoint Steve Krognes as Non-Executive Director
- Argenx reports preliminary Q4 Vyvgart revenue $175M
- argenx Highlights 2023 Strategic Priorities Across Immunology Pipeline
- Argenx price target raised to EUR 500 from EUR 480 at JPMorgan
- Argenx included on Wells Fargo’s Tactical Ideas List for Q1 2023
